Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1319
http://purl.obolibrary.org/obo/NCIT_C1319
|
|---|---|
| Preferred Name | Leuprolide Acetate |
| Definitions |
The acetate salt of a synthetic nonapeptide analogue of gonadotropin-releasing hormone. Leuprolide binds to and activates gonadotropin-releasing hormone (GnRH) receptors. Continuous, prolonged administration of leuprolide in males results in pituitary GnRH receptor desensitization and inhibition of pituitary secretion of follicle stimulating hormone (FSH) and luteinizing hormone (LH), leading to a significant decline in testosterone production; in females, prolonged administration results in a decrease in estradiol production. This agent reduces testosterone production to castration levels and may inhibit androgen receptor-positive tumor progression.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | The acetate salt of a synthetic nonapeptide analogue of gonadotropin-releasing hormone. Leuprolide binds to and activates gonadotropin-releasing hormone (GnRH) receptors. Continuous, prolonged administration of leuprolide in males results in pituitary GnRH receptor desensitization and inhibition of pituitary secretion of follicle stimulating hormone (FSH) and luteinizing hormone (LH), leading to a significant decline in testosterone production; in females, prolonged administration results in a decrease in estradiol production. This agent reduces testosterone production to castration levels and may inhibit androgen receptor-positive tumor progression. |
|---|---|
| prefLabel | Leuprolide Acetate
|
| label | Leuprolide Acetate
|
| CHEBI_ID | CHEBI:63597
|
| PDQ_Closed_Trial_Search_ID | 40058
|
| code | C1319
|
| Has_Target | |
| prefixIRI | NCIT:C1319
|
| in_subset |
See more
See less
|
| Display_Name | Leuprolide Acetate
|
| Preferred_Name | Leuprolide Acetate
|
| FDA_UNII_Code | 37JNS02E7V
|
| Contributing_Source |
CTRP
FDA
|
| Chemical_Formula | C59H84N16O12.C2H4O2
|
| Maps_To | Leuprolide Acetate
|
| CAS_Registry | 74381-53-6
|
| NSC Number | 377526
|
| NCI_Drug_Dictionary_ID | 40058
|
| Legacy Concept Name | Leuprolide
|
| Has_Free_Acid_Or_Base_Form | |
| type | |
| ALT_DEFINITION | A drug used to treat symptoms of advanced prostate cancer. It is also being studied in the treatment of other conditions and types of cancer. The active ingredient leuprolide blocks the body from making testosterone (a male hormone) and estradiol (a female hormone). It may stop the growth of prostate cancer cells that need testosterone to grow. Some brands of leuprolide are also used to treat early puberty in children and certain gynecologic conditions. Leuprolide acetate is a type of gonadotropin-releasing hormone analog.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 40058
|
| Accepted_Therapeutic_Use_For | Endometriosis; In-vitro fertilization; Precocious puberty; Premenstrual syndrome; Prostate cancer; Uterine fibroid tumors
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
|
| UMLS_CUI | C0700596
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |